Michael A Gorin1, Mark W Ball2, Phillip M Pierorazio2, Pedram Argani3, Mohamad E Allaf2. 1. The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: mgorin1@jhmi.edu. 2. The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD. 3. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: The aim of this study was to evaluate the outcome of patients with translocation renal cell carcinoma (RCC) treated with partial nephrectomy. PATIENTS AND METHODS: Our institutional review board-approved renal mass registry was queried for patients who underwent partial nephrectomy for a pathologically confirmed translocation RCC. We describe the demographic, clinical, pathological, and follow-up data for this series of patients. RESULTS: Between 2003 and 2013, 1897 patients with RCC were treated at our institution with a radical or partial nephrectomy. In total, 10 (0.5%) patients were diagnosed with a translocation RCC. Of these patients, 4 (40%) underwent treatment with partial nephrectomy for an incidentally detected small renal mass (mean imaging diameter, 2.6 cm [range, 1.0-4.2 cm]). During a mean follow-up of 37 months (range, 8-81 months), all patients were alive without evidence of disease. CONCLUSION: At short-term follow-up, partial nephrectomy appears to be an effective treatment option for patients with small translocation RCCs. Larger studies are required to more extensively investigate the optimal treatment of these potentially aggressive tumors.
BACKGROUND: The aim of this study was to evaluate the outcome of patients with translocation renal cell carcinoma (RCC) treated with partial nephrectomy. PATIENTS AND METHODS: Our institutional review board-approved renal mass registry was queried for patients who underwent partial nephrectomy for a pathologically confirmed translocation RCC. We describe the demographic, clinical, pathological, and follow-up data for this series of patients. RESULTS: Between 2003 and 2013, 1897 patients with RCC were treated at our institution with a radical or partial nephrectomy. In total, 10 (0.5%) patients were diagnosed with a translocation RCC. Of these patients, 4 (40%) underwent treatment with partial nephrectomy for an incidentally detected small renal mass (mean imaging diameter, 2.6 cm [range, 1.0-4.2 cm]). During a mean follow-up of 37 months (range, 8-81 months), all patients were alive without evidence of disease. CONCLUSION: At short-term follow-up, partial nephrectomy appears to be an effective treatment option for patients with small translocation RCCs. Larger studies are required to more extensively investigate the optimal treatment of these potentially aggressive tumors.
Authors: Maria Carmen Mir; Enrique Trilla; Ines Maria de Torres; Angel Panizo; Alexander R Zlotta; Bas Van Rhijn; Juan Morote Journal: BJU Int Date: 2010-11-10 Impact factor: 5.588
Authors: Steven C Campbell; Andrew C Novick; Arie Belldegrun; Michael L Blute; George K Chow; Ithaar H Derweesh; Martha M Faraday; Jihad H Kaouk; Raymond J Leveillee; Surena F Matin; Paul Russo; Robert G Uzzo Journal: J Urol Date: 2009-08-14 Impact factor: 7.450
Authors: Ian J Davis; Bae-Li Hsi; Jason D Arroyo; Sara O Vargas; Y Albert Yeh; Gabriela Motyckova; Patricia Valencia; Antonio R Perez-Atayde; Pedram Argani; Marc Ladanyi; Jonathan A Fletcher; David E Fisher Journal: Proc Natl Acad Sci U S A Date: 2003-04-28 Impact factor: 11.205
Authors: Börje Ljungberg; Nigel C Cowan; Damian C Hanbury; Milan Hora; Markus A Kuczyk; Axel S Merseburger; Jean-Jacques Patard; Peter F A Mulders; Ioanel C Sinescu Journal: Eur Urol Date: 2010-07-12 Impact factor: 20.096
Authors: Mohamad E Allaf; Sam B Bhayani; Craig Rogers; Ioannis Varkarakis; Richard E Link; Takeshi Inagaki; Thomas W Jarrett; Louis R Kavoussi Journal: J Urol Date: 2004-09 Impact factor: 7.450
Authors: James I Geller; Pedram Argani; Adebowale Adeniran; Edith Hampton; Angelo De Marzo; Jessica Hicks; Margaret H Collins Journal: Cancer Date: 2008-04-01 Impact factor: 6.860
Authors: Pedram Argani; Semra Olgac; Satish K Tickoo; Michael Goldfischer; Holger Moch; David Y Chan; John N Eble; Stephen M Bonsib; Mireya Jimeno; Josep Lloreta; Athanase Billis; Jessica Hicks; Angelo M De Marzo; Victor E Reuter; Marc Ladanyi Journal: Am J Surg Pathol Date: 2007-08 Impact factor: 6.394
Authors: Ellen M Chung; Grant E Lattin; Kimberly E Fagen; Andrew M Kim; Michael A Pavio; Adam J Fehringer; Richard M Conran Journal: Radiographics Date: 2017 Sep-Oct Impact factor: 5.333